2018
Breast cancer histopathology is predictive of low‐risk Oncotype Dx recurrence score
Wilson PC, Chagpar AB, Cicek AF, Bossuyt V, Buza N, Mougalian S, Killelea BK, Patel N, Harigopal M. Breast cancer histopathology is predictive of low‐risk Oncotype Dx recurrence score. The Breast Journal 2018, 24: 976-980. PMID: 30230117, DOI: 10.1111/tbj.13117.Peer-Reviewed Original ResearchConceptsLymph node-negative patientsNode-negative patientsOncotype DX testingInvasive carcinomaLow-grade invasive carcinomasHistologic subtypeOncotype DXRecurrence scoreEstrogen receptorHigh riskAJCC Breast Cancer Staging SystemBreast cancer staging systemOncotype DX recurrence scoreFavorable histologic subtypeOncotype recurrence scoreSimple multivariable modelsCancer (AJCC) staging systemRisk of recurrenceDX recurrence scoreOnly significant predictorExcellent prognosisIntermediate riskDuctal carcinomaHistologic gradeHistologic predictors
2010
Breast Cytology: Current Issues and Future Directions
Harigopal M, Chhieng D. Breast Cytology: Current Issues and Future Directions. The Open Breast Cancer Journal 2010, 4: 81-89. DOI: 10.2174/1876817201002011081.Peer-Reviewed Original ResearchFine-needle aspiration biopsyCore needle biopsySame-day diagnosisBreast cytologySentinel lymph nodesNeedle aspiration biopsyTouch preparation cytologyLymph nodesSurgical marginsDuctal lavageExperienced handsIntraoperative evaluationFluid cytologyTherapeutic responseNeedle biopsyPatient outcomesPrognostic markerBreast cancerAncillary testingSitu carcinomaEarly cancer detectionAspiration biopsyHigh riskExperienced cytopathologistCytology